Custom positive controls are intentionally defective packaging samples developed to support Container Closure Integrity Testing (CCIT) when standard reference samples cannot adequately represent the intended container, leakage pathway, or testing conditions.

Pharmaceutical and medical device packaging can vary significantly in shape, material, closure design, and internal structure. Examples include BFS containers, IV bags, prefilled syringes, multi-chamber packaging, and specialty sterile barrier systems.

For these packages, selecting a positive control involves more than specifying a nominal defect size. The defect structure, location, packaging material, product condition, and leak testing method must all be considered.

This guide explains when customized positive controls are needed, how different defect structures are selected, and what information is required for CCIT method development and validation.

1. When Are Custom Positive Controls Needed?

A standard positive control may be suitable when its packaging configuration and leakage characteristics adequately represent the intended testing application.

Customization should be considered when the standard sample cannot address an important aspect of the actual product-package system.

Typical situations include:

• Unusual container geometry: The packaging has a nonstandard shape, dimensions, or internal structure.

• Special packaging materials: Flexible films, multilayer materials, or polymers require different approaches to creating controlled defects.

• Complex closure systems: The relevant leakage pathway occurs at a specific sealing interface or component connection.

• Specific defect locations: The study requires a defect in a region not represented by available standard samples.

• Method-specific requirements: The selected CCIT technology requires a characterized leakage pathway under particular testing conditions.

• Product-specific validation: The positive control must reflect relevant fill volume, headspace, or product conditions.

Customization is not inherently more accurate than a standard positive control. Its purpose is to provide a reference sample suitable for a testing requirement that standard configurations cannot adequately address.

2. What Types of Custom Positive Controls Are Available?

ZHOLION provides several positive control technologies for pharmaceutical package integrity testing. The appropriate structure depends on the package material, expected defect, and CCIT method.

Positive Control Type	Defect Structure	Relevant Applications	Selection Considerations
Laser Drilling Positive Control	A micro-hole created directly in suitable packaging material	Vials, ampoules, syringe barrels, and compatible rigid or polymer containers	Material, wall thickness, hole size, location, and surrounding material condition
Micropipette Positive Control	A precision glass capillary incorporated into the package to form a leakage pathway	Pharmaceutical packages that can accommodate the capillary arrangement	Internal diameter, capillary length, implantation position, and test conditions
Capillary Positive Control	A characterized capillary leakage channel	Packaging studies requiring a defined leakage pathway	Capillary geometry, connection integrity, test medium, and pressure conditions
Natural Defects Positive Control	A representative packaging defect or failure condition	Studies of actual sealing or material failure mechanisms	Defect representativeness, characterization, stability, and reproducibility

These approaches are not automatically interchangeable.

For example, a laser-drilled opening in a vial body provides a different leakage geometry from a defect at the stopper-to-vial interface. Similarly, a capillary leakage pathway may not reproduce the mechanical behavior of a naturally occurring package crack.

The positive control design should reflect the intended validation objective.

3. Selecting Positive Controls for Different Non-Standard Packaging Types

Different packaging systems present distinct challenges for defect creation and characterization.

Packaging Type	Main Packaging Characteristics	Positive Control Design Considerations
BFS Bottles and Ampoules	One-piece polymer containers with formed and sealed regions	Polymer behavior, wall thickness, accessible defect location, and seal geometry
IV Bags	Flexible polymer film with welded seals and ports	Film deformation, seal defects, port interfaces, and product fill conditions
Prefilled Syringes	Barrel, plunger stopper, tip cap, or needle shield	Relevant leakage interface, component movement, fill level, and barrel material
Multi-Chamber Packaging	Multiple compartments separated by internal seals or barriers	Target compartment, internal seal arrangement, and intended leakage pathway
Specialty Vials	Unusual vial geometry or closure configuration	Accessible defect position, glass or polymer material, headspace, and closure structure
Sterile Medical Device Packaging	Pouches, trays, porous materials, or multilayer sterile barrier systems	Material structure, seal location, defect geometry, and applicable integrity test

BFS Containers

Blow-Fill-Seal (BFS) containers combine container forming, filling, and sealing within an integrated manufacturing process.

Custom positive control development should consider polymer material, wall geometry, container flexibility, and potential leakage at formed or sealed regions.

A controlled opening in the container wall may be useful for evaluating detection capability, but it does not necessarily reproduce a defect in the BFS sealing region.

IV Bags and Flexible Packaging

Flexible pharmaceutical packaging may deform under pressure changes.

For vacuum decay testing, package movement and chamber conditions may influence the measured response. Positive controls should therefore be evaluated under representative filling and testing conditions.

Defects in the film, welded seams, and ports may require different positive control configurations.

Prefilled Syringes

A prefilled syringe contains several potential leakage interfaces, including the plunger stopper, tip closure, and barrel.

A laser-drilled barrel defect can support studies of leakage through the container wall. However, it should not automatically be used as a direct representation of plunger or tip closure leakage.

The appropriate positive control depends on which failure mechanism the method needs to detect.

Multi-Chamber Packaging

Multi-chamber packaging may contain internal seals and separate product compartments.

Positive control development should identify whether the study concerns leakage to the external environment or unintended communication between compartments.

These are different integrity requirements and may require different defect locations and evaluation procedures.

4. Which Parameters Should Be Defined Before Customization?

A technically useful positive control specification should describe the complete leakage configuration rather than a nominal defect diameter alone.

Design Parameter	What Needs to Be Defined
Packaging Material	Glass, polymer, flexible film, multilayer structure, or another material
Package Dimensions	External dimensions, wall thickness, and relevant geometry
Closure System	Stopper, cap, welded seal, port, plunger, or other interface
Defect Structure	Laser-drilled hole, micropipette, capillary, or representative defect
Defect Size	Target opening or internal diameter, with applicable tolerance
Leakage Path Length	Relevant channel length or material thickness
Defect Location	Position relative to the closure, headspace, or liquid fill
Product Condition	Empty, liquid-filled, lyophilized, or another relevant configuration
Testing Method	Vacuum decay, helium leak testing, HVLD, dye ingress, or another method
Documentation	Required dimensional characterization, leakage data, and traceability records

The nominal size of a defect should not be treated as a universal leakage rate.

Actual leakage depends on factors such as pathway geometry, pressure differential, temperature, test medium, and wetting conditions.

Where a study requires a defined leak rate, the characterization procedure and measurement conditions should be specified.

5. Matching Custom Positive Controls to CCIT Methods

Different CCIT methods measure different physical responses. Positive controls must therefore be evaluated using the intended testing principle.

CCIT Method	Measurement Principle	Custom Positive Control Considerations
Vacuum Decay	Pressure changes in an evacuated test chamber	Package deformation, chamber volume, defect location, fill conditions, and pressure response
Helium Leak Testing	Helium tracer-gas measurement using mass spectrometry	Tracer-gas preparation, leakage pathway, chamber conditions, and helium response
High Voltage Leak Detection (HVLD)	Electrical changes associated with suitable leakage defects	Product conductivity, container material, liquid coverage, and defect position
Laser-Based Headspace Analysis	Changes in selected headspace gas characteristics	Initial gas composition, internal pressure, defect location, and exposure conditions
Dye Ingress	Penetration of dye through a leakage pathway	Dye properties, pressure differential, immersion period, and defect wetting
Microbial Ingress	Microorganism penetration under defined challenge conditions	Defect characteristics, challenge organism, exposure conditions, and microbial transport

Vacuum Decay Testing

A custom positive control should generate a relevant pressure response under the established test conditions.

For flexible or unusual packaging, chamber volume, packaging deformation, product fill, and pressure stabilization should be investigated.

Helium Leak Testing

A custom positive control should provide a suitable pathway for tracer-gas measurement.

The test procedure must establish appropriate helium preparation, chamber conditions, and background control.

HVLD and Other Methods

For HVLD, a physical opening does not guarantee a detectable electrical response. Product conductivity, fill conditions, and defect location must also be considered.

Similarly, positive controls used in dye ingress or microbial ingress studies must be suitable for the applicable challenge mechanism.

A positive control that performs as expected in one method cannot automatically be assumed to provide an equivalent response in another.

6. How Are Custom Positive Controls Developed and Verified?

A custom positive control project can be organized into five stages.

Step 1: Define the Package and Testing Objective

Collect the packaging specifications, product conditions, intended CCIT method, and relevant leakage requirements.

Identify the failure mechanism that the positive control is intended to represent.

Step 2: Select the Defect Configuration

Determine whether laser drilling, a micropipette, a capillary, or a representative natural defect is suitable.

Evaluate material compatibility, defect accessibility, and whether the selected structure can address the testing objective.

Step 3: Prepare the Positive Control

Create the specified leakage pathway using a suitable manufacturing or sample preparation process.

The preparation procedure should avoid unintended damage that could introduce additional uncontrolled leakage paths.

Step 4: Characterize and Test the Sample

Confirm the relevant defect characteristics and evaluate the sample using appropriate testing conditions.

Depending on the intended use, characterization may include dimensional examination, leakage measurement, and repeatability testing.

Step 5: Establish Documentation and Use Conditions

Document the positive control identification, relevant specifications, available characterization results, and intended use.

Where the sample will support routine system suitability testing, establish appropriate handling, verification, and replacement criteria.

7. Custom Positive Controls in CCIT Method Validation

Positive controls support method validation by providing known defective samples against which the test method can be challenged.

For non-standard packaging, validation should address the relationship between the selected defect and the actual container closure system.

Detection Capability

The method should demonstrate that it can detect defects relevant to the established integrity requirements.

A positive control with a known opening is useful, but the measured response must be evaluated under defined conditions.

Repeatability

Repeated tests can help determine whether the system produces consistent results when challenged with the same positive control.

Robustness

Validation may examine the influence of normal variations in packaging dimensions, product conditions, chamber settings, and measurement parameters.

Defect Representativeness

An engineered defect does not necessarily reproduce every naturally occurring failure mechanism.

Where relevant, different positive control designs may be required to evaluate container-wall defects and closure-interface defects.

Regulatory Considerations

USP <1207> provides a scientific framework for pharmaceutical package integrity evaluation and method validation.

Custom positive controls can support this process, but their use does not independently establish compliance. The overall method must be demonstrated to be suitable for its intended application.

8. Standard vs. Custom Positive Controls

The decision should be based on application requirements, not an assumption that customized samples provide superior test performance.

Comparison Factor	Standard Positive Controls	Custom Positive Controls
Container Configuration	Established packaging formats	Project-specific packaging formats
Defect Structure	Available standard defect configurations	Selected according to the intended study
Defect Position	Available standard locations	Project-specific locations, subject to feasibility
Characterization	According to the standard sample specification	According to the agreed custom specification
CCIT Validation	Suitable when the standard sample represents the intended application	Suitable when application-specific characteristics must be represented
Preparation Requirements	Established preparation process	May require additional feasibility and development work
Documentation	Standard sample documentation	Documentation corresponding to the customized configuration

For common pharmaceutical vials, a standard laser-drilled positive control may be sufficient for a particular method development study.

For an unusual BFS container, a flexible IV bag, or a specialized closure system, additional customization may be necessary.

The selected sample should be justified by its suitability for the intended testing objective.

9. What Should Buyers Provide When Requesting Custom Positive Controls?

Before ordering, buyers should provide:

• Container information: Package type, dimensions, material, and technical drawings.

• Closure information: Stopper, seal, port, plunger, or other relevant interfaces.

• Product conditions: Fill volume, formulation type, headspace, and internal pressure where applicable.

• Target defect: Required size, geometry, and location.

• CCIT method: The technology and relevant measurement conditions.

• Testing purpose: Method development, validation, system suitability testing, or investigation.

• Documentation: Required characterization, calibration, and traceability information.

• Quantity: Number of samples and whether multiple defect levels are required.

If the target defect size has not been established, it should be determined through the integrity assessment and method development process rather than selected arbitrarily.

10. Custom Positive Control Solutions from Zholion

Founded in 2005, Zholion provides pharmaceutical packaging integrity testing equipment, positive controls, and technical services.

Its CCIT Positive Controls include laser-drilled, micropipette, capillary, and natural-defect configurations for different packaging and testing requirements.

Zholion also supports customers through:

• Custom positive control sample development.

• Container closure integrity testing method development and validation.

• Test chambers for different packaging configurations.

• Third-party package integrity testing.

• Regulatory documentation and audit support.

For non-standard pharmaceutical packaging, Zholion can help evaluate the container configuration, intended defect characteristics, and testing method to determine a suitable positive control approach.

Contact Zholion with your package drawings, defect requirements, and CCIT validation objectives to discuss technical feasibility and customization options.

Frequently Asked Questions

What is a custom positive control for package integrity testing?

A custom positive control is an intentionally defective sample developed for a specific packaging configuration or testing requirement. It provides a characterized leakage pathway for evaluating a leak detection method.

Does every non-standard package require a custom positive control?

Not necessarily. An existing standard sample may be suitable if it adequately represents the intended testing conditions and defect characteristics.

Can custom positive controls be developed for BFS containers and IV bags?

These packaging types may require customized defect configurations. Feasibility depends on the material, geometry, defect location, and testing objective.

Is a laser-drilled hole equivalent to a natural packaging defect?

No. A laser-drilled hole provides an engineered opening, while a natural crack or sealing defect may have a different geometry and leakage behavior.

Can one positive control be used for vacuum decay and helium leak testing?

The same physical sample may be evaluated using both methods if suitable, but its response and acceptance criteria must be established separately.

How is the defect size selected?

Defect size should be linked to the relevant integrity requirement, expected leakage pathway, testing method, and method detection capability.

What documentation should accompany a custom positive control?

Depending on the application, documentation may include sample identification, defect specifications, characterization results, calibration records, and relevant test conditions.

Conclusion

Custom positive controls support package integrity testing when standard reference samples cannot adequately represent the actual packaging system or testing requirement.

For non-standard pharmaceutical packaging, selection should consider material, geometry, closure design, defect structure, product condition, and CCIT method.

A suitable positive control is not defined by nominal defect size alone. Its relevance to the intended leakage mechanism and its behavior under established test conditions are equally important.

Zholion provides customized positive control options and CCIT technical services to support method development, validation, and package integrity evaluation.